The efficient detection of such novel tumor recognizing CD8+ T cells is most likely due to the use of the functional screening platform, which relies on the identification of T cells among TILs that respond to endogenously presented antigen on APC rather than on the identification of predicted epitopes. Here, CD8A is linked to neoplasm.